HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mary Kay recycles

This article was originally published in The Rose Sheet

Executive Summary

With launch of new eco-friendly compact, company launches Mary Kay Compact Recycling Drive. Compact features innovative refill system expected to eliminate 60 million units of packaging and cut back on more than 60,000 tons of carbon emissions, according to June 16 release. Consumers are invited to turn in previous Mary Kay compacts to Independent Beauty Consultants or by going to 1www.marykay.com. For every compact returned, company will plant a tree in Montana and Idaho's Bitterfoot National Forest, with the goal of planting an entire forest. Mary Kay Compact, available "with 18 million possible color combinations," features sheer pressed powder, eye color, cheek color, bronzing and highlighting powders, and lip colors. Each powder product is "completely mineral-based, on trend and a nourishing catalyst to luminescent, younger-looking skin," Mary Kay says...

You may also be interested in...

Health And Wellness Trademark Review 14 January, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.

Deal Watch: Novo Nordisk, Fauna To Explore Hibernation To Treat Obesity

A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts